Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 17 Feb 2026 for ANI Pharmaceuticals INC, €37k. Read the official filing
Filing timeline
BuySaleThomas Andrew Rowland
Insider track record
Disclosed buys
0
Disclosed sells
2
T+90 hit rate
25%
T+90 mean return
-1.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Thomas Andrew Rowland: trading record in brief
Thomas Andrew Rowland is a declared insider of ANI Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Between 15 November 2024 and 11 March 2026, the trades on record add up to 11 filings.
The open-market record consists of 2 sales worth €673k, with no purchase. Other entries cover 9 share grants. Since January 2026: no purchases and 1 sale on the market.
On 13 March 2026 came the latest disclosure, an open-market sale for €308k in ANI Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Thomas Andrew Rowland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
566 shares@ US$76.7019.8% of flowCommon StockSEC:0001507496-26-000005:0
485 shares@ US$77.3617.1% of flowCommon StockSEC:0001507496-26-000005:1
4,975 shares@ US$85.71Common StockSEC:0001507496-25-000007:0
627 shares@ US$61.8920.2% of flowCommon StockSEC:0001507496-25-000004:0
7,834 shares0Common StockSEC:0001507496-25-000002:0
5,222 shares0Common StockSEC:0001507496-25-000002:1
582 shares@ US$58.9217.7% of flowCommon StockSEC:0001507496-25-000002:2
867 shares@ US$56.5825.2% of flowCommon StockSEC:0001507496-24-000006:0
8 of 8 declarations
